Human complementarity determining region (cdr) - grafted...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 51/10 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01) G01N 33/92 (2006.01)

Patent

CA 2226400

A human CDR-grafted antibody which specifically reacts with ganglioside CM2, wherein said antibody comprises CDR 1, CDR 2 and CDR 3 of heavy chain (H chain) variable region (V region) comprising amino acid sequences described in SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3, and CDR 1, CDR 2 and CDR 3 of light chain (L chain) V region comprising amino acid sequences described in SEQ ID NO:4, SEQ ID NO: 5 and SEQ ID NO:6, and wherein at least one of the frameworks (FR) of said H chain and L chain V regions comprises an amino acid sequence selected from common sequences (HMECS; human most homologous consensus sequence) derived from human antibody subgroups.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human complementarity determining region (cdr) - grafted... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human complementarity determining region (cdr) - grafted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human complementarity determining region (cdr) - grafted... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1663324

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.